Most Read Articles
5 days ago
Living a sedentary lifestyle may increase the risk of cardiovascular diseases (CVD) even in people with healthy body mass index (BMI), reports a new study.
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
3 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.

Unspecified diagnosis of infectious disease prompts unnecessary antibiotic use

06 Dec 2018

Noninfectious syndromes often lead to unnecessary antibiotic therapy, with risk factors including unspecified diagnosis of infectious disease and the absence of microbial testing, a study reports.

Researchers analysed 453 curative antibiotic therapies prescribed over 2 consecutive days through the same electronic medical records, obtaining data on the reason for hospitalization, comorbid conditions, suspected or definitive diagnosis of infection, and microbial analyses. They defined unnecessary antibiotic therapy as the recognition of noninfectious syndromes, nonbacterial infections, use of redundant antimicrobials and continuation of empirical broad-spectrum antimicrobials.

Hospitalization occurred in 201 cases (44 percent) due to an infectious disease. The main diagnoses were urinary tract infections (n=118; 26 percent), unspecified (n=104; 22 percent) and pulmonary infections (n=79; 17 percent). A total of 158 noninfectious syndromes were identified (35 percent).

An unspecified diagnosis occurred with greater frequency in the presence of a noninfectious syndrome: 60/104 vs 98/349 (58 percent vs 28 percent; p<0.001). Microbial samples were obtained in 296 cases (65 percent), allowing isolation of a pathogen in 156 cases (53 percent).

Unspecified diagnosis was significantly associated with the absence of a microbial sample (p=0.005). There were 169 cases (37 percent) of unnecessary antibiotic therapy, of which 106 were due to noninfectious syndromes.

Multivariate logistic regression analysis revealed two the modifiable risk factors for unnecessary antibiotic therapy, namely unspecified diagnosis (adjusted odds ratio [AOR], 1.83; 95 percent CI, 1.04–3.20) and absence of a blood culture (AOR, 5.26; 2.56–10.00).

In light of the present data, antimicrobial stewardship programmes should focus on diagnostic difficulties and microbial testing, with the latter facilitating antibiotic reassessment and therapeutic interruption.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
Living a sedentary lifestyle may increase the risk of cardiovascular diseases (CVD) even in people with healthy body mass index (BMI), reports a new study.
04 Feb 2019
The carbon-chain length of saturated fatty acids appears to be an important factor in determining its role in cardiovascular health, a recent study has found.
3 days ago
Olanzapine confers a modest therapeutic effect on weight compared with placebo in adult outpatients with anorexia nervosa, a study has shown. However, it does not appear to offer significant benefit for psychological symptoms.
Jairia Dela Cruz, 04 Feb 2019
Treatment with secukinumab results in a higher rate of remission or low-disease activity at week 16 in patients with psoriatic arthritis as compared with placebo, according to a posthoc analysis of the FUTURE 2 study. This effect is sustained at 2 years and is evident in both tumour necrosis factor inhibitor-experienced and -naïve patients.